Myocardial dysfunction in donor hearts. A possible etiology

V J Owen1, P B Burton, M C Michel

  • 1Cardiothoracic Surgery, National Heart and Lung Institute at Imperial College School of Medicine, London, UK. v.j.owen@ic.ac.uk

Circulation
|May 20, 1999
PubMed

Insights

Increased inhibitory G protein Gialpha activity contributes to impaired contractility in acutely failing donor hearts. This contrasts with changes in calcium-handling proteins and beta-adrenoceptor density, which were not common causes.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Transplantation Science

Background:

  • Unused donor hearts often exhibit myocardial dysfunction, rendering them unsuitable for transplantation.
  • The underlying mechanisms of acute heart failure in these hearts remain unclear.
  • This study investigates potential causes including calcium-handling proteins, beta-adrenoceptor density, and inhibitory G protein Gialpha.

Purpose of the Study:

  • To determine the molecular basis of contractile dysfunction in acutely failing donor hearts.
  • To compare alterations in unused donor hearts with those in end-stage failing and nonfailing hearts.
  • To identify key protein targets contributing to impaired cardiac function.

Main Methods:

  • Analysis of myocardial samples from unused donor hearts (ejection fraction <30%), end-stage failing hearts, and nonfailing hearts.
  • In vitro assessment of inotropic function in trabeculae and isolated myocytes.
  • Quantification of specific calcium-handling proteins (SERCA, NCX), beta-adrenoceptor density, and Gialpha activity.

Main Results:

  • Unused donor hearts showed contractile dysfunction comparable to failing hearts.
  • Alterations in sarcoplasmic reticulum calcium-ATPase and sodium-calcium exchanger abundance were not common to both groups.
  • Beta-adrenoceptor density was reduced in failing hearts but not in unused donor hearts.
  • Increased inhibitory G protein Gialpha activity was observed in both unused donor and failing hearts.

Conclusions:

  • Elevated Gialpha activity is a significant factor in the impaired contractility of acutely failing donor hearts.
  • This finding differentiates the mechanism from alterations in calcium-handling proteins or beta-adrenoceptor density.
  • Targeting Gialpha may offer therapeutic potential for preserving cardiac function in donor hearts.
Abstract

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...